Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review

Carregando...
Imagem de Miniatura
Citações na Scopus
69
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
ACADEMIC PRESS INC ELSEVIER SCIENCE
Autores
MAESTA, Izildinha
BRAGA, Antonio
SUN, Sue Y.
ELIAS, Kevin M.
HOROWITZ, Neil
GOLDSTEIN, Donald P.
BERKOWITZ, Ross S.
Citação
GYNECOLOGIC ONCOLOGY, v.145, n.1, p.88-95, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective. To determine the clinical characteristics of multiple gestation with complete mole and coexisting fetus (CHMCF) in North and South America. Methods. Retrospective non-concurrent cohorts compromised of CHMCF from New England Trophoblastic Disease Center (NETDC) (1966-2015) and four Brazilian Trophoblastic Disease Centers (BTDC) (1990-2015). Results. From a total of 12,455 cases of gestational trophoblastic disease seen, 72 CHMCF were identified. Clinical characteristics were similar between BTDC (n = 46) and NETDC (n = 13) from 1990 to 2015, apart from a much higher frequency of potentially life-threatening conditions in Brazil (p = 0.046). There were no significant changes in the clinical presentation or outcomes over the past 5 decades in NETDC (13 cases in 1966-1989 vs 13 cases in 1990-2015). Ten pregnancies were electively terminated and 35 cases resulted in viable live births (60% of 60 continued pregnancies). The overall rate of gestational trophoblastic neoplasia (GTN) was 46%; the cases which progressed to GTN presented with higher chorionic gonadotropin levels (p = 0.026) and higher frequency of termination of pregnancy due to medical complications (p = 0.006) when compared to those with spontaneous remission. Conclusions. The main regional difference in CHMCF presentation is related to a higher rate of potentially life threatening conditions in South America. Sixty percent of the expectantly managed CHMCF delivered a viable infant, and the overall rate of GTN in this study was 46%. Elective termination of pregnancy did not influence the risk for GTN; however the need for termination due to complications and higher hCG levels were associated with development of GTN in CHMCF.
Palavras-chave
Gestational trophoblastic disease, Hydatidiform mole, Pregnancy, Twin, Multiple, Pregnancy, Trophoblastic neoplasms, Near miss, healthcare
Referências
  1. Berkowitz RS, 2009, NEW ENGL J MED, V360, P1639, DOI 10.1056/NEJMcp0900696
  2. Cagayan MSFS, 2014, J REPROD MED, V59, P235
  3. Elliott P., 2014, GEOGRAPHIC PATTERNS, P1
  4. Fishman DA, 1998, OBSTET GYNECOL, V91, P546, DOI 10.1016/S0029-7844(97)00720-5
  5. Kihara M, 2012, J REPROD MED, V57, P325
  6. Kutuk MS, 2014, J CLIN ULTRASOUND, V42, P465, DOI 10.1002/jcu.22169
  7. Lee SW, 2010, J ULTRAS MED, V29, P271
  8. Massardier J, 2009, EUR J OBSTET GYN R B, V143, P84, DOI 10.1016/j.ejogrb.2008.12.006
  9. Matsui H, 2000, HUM REPROD, V15, P608, DOI 10.1093/humrep/15.3.608
  10. Ngan HYS, 2012, INT J GYNECOL OBSTET, V119, pS130, DOI 10.1016/S0020-7292(12)60026-5
  11. Niemann I., 2013, 17 WORLD C GEST TROP, P57
  12. Niemann I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/jajog.2007.02.038
  13. Okumura M, 2014, J ULTRAS MED, V33, P177, DOI 10.7863/ultra.33.1.177
  14. Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
  15. Sebire NJ, 2002, LANCET, V359, P2165, DOI 10.1016/S0140-6736(02)09085-2
  16. Soares RR, 2016, GYNECOL ONCOL, V142, P496, DOI 10.1016/j.ygyno.2016.07.002
  17. STELLER MA, 1994, OBSTET GYNECOL, V83, P35
  18. Sun SY, 2016, J REPROD MED, V61, P210
  19. Sun SY, 2016, INT J GYNECOL CANCER, V26, P367, DOI 10.1097/IGC.0000000000000608
  20. Sun SY, 2015, GYNECOL ONCOL, V138, P46, DOI 10.1016/j.ygyno.2015.05.002
  21. VEJERSLEV L O, 1991, Obstetrical and Gynecological Survey, V46, P577, DOI 10.1097/00006254-199109000-00001
  22. von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
  23. Wee L, 2005, PRENATAL DIAG, V25, P772, DOI 10.1002/pd.1272
  24. WHO recommendations on the interventions to improve preterm birth outcomes, WHO REC INT IMPR PRE